Julien Zuber Selected Research

Complement System Proteins (Complement)

2/2024	Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic Syndrome.
2/2024	De novo thrombotic microangiopathy after kidney transplantation in adults: Interplay between complement genetics and multiple endothelial injury.
11/2023	Targeting the Complement Pathway in Kidney Transplantation.
11/2023	Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN.
1/2023	Complement-driven hemolytic uremic syndrome.
12/2019	Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.
12/2019	Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome.
8/2017	Haemolytic uraemic syndrome.
8/2013	Physiological and therapeutic complement regulators in kidney transplantation.
7/2013	Eculizumab in renal transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julien Zuber Research Topics

Disease

10	Infections 09/2023 - 12/2010
8	Atypical Hemolytic Uremic Syndrome 02/2024 - 04/2013
6	Thrombotic Microangiopathies 02/2024 - 07/2002
4	Hemolytic-Uremic Syndrome 02/2024 - 01/2011
4	Neoplasms (Cancer) 01/2021 - 05/2012
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 12/2011
4	Inflammation (Inflammations) 05/2015 - 04/2008
3	Kidney Diseases (Kidney Disease) 02/2024 - 04/2013
3	COVID-19 01/2022 - 01/2021
3	Diarrhea 01/2017 - 07/2011
3	Lymphopenia (Lymphocytopenia) 03/2016 - 08/2005
2	Renal Insufficiency (Renal Failure) 02/2024 - 04/2008
2	Brain Death (Brain Dead) 11/2023 - 08/2013
2	Hypertension (High Blood Pressure) 01/2023 - 01/2012
2	X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation 01/2021 - 05/2007
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 10/2006
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2017 - 11/2010
2	Cryptosporidiosis 01/2017 - 10/2014
2	Proteinuria 04/2010 - 09/2007
1	Communicable Diseases (Infectious Diseases) 11/2023
1	Ischemia 11/2023
1	Intermediate Uveitis (Chronic Cyclitis) 09/2023
1	Anterior Uveitis 09/2023
1	Membranous Glomerulonephritis (Membranous Nephropathy) 12/2022
1	COVID-19 rebound 01/2022
1	Fever (Fevers) 01/2022
1	Late Onset Disorders 01/2021
1	Primary Immunodeficiency Diseases 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Hypertensive Crisis 12/2019
1	Viremia 05/2019
1	Rare Diseases (Rare Disease) 12/2017
1	Pathologic Complete Response 12/2017
1	Opportunistic Infections (Opportunistic Infection) 03/2016
1	Protozoan Infections 10/2014
1	Dehydration (Water Stress) 10/2014
1	Delayed Graft Function 07/2013
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 07/2013
1	Reperfusion Injury 07/2013
1	Glomerulonephritis 08/2012
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 08/2012
1	Carcinogenesis 12/2011
1	Weight Loss (Weight Reduction) 07/2011
1	Parasitic Diseases (Parasitic Disease) 07/2011
1	Arteriosclerosis 05/2011
1	Vasculitis (Vasculitides) 05/2011
1	Atrophy 01/2011

Drug/Important Bio-Agent (IBA)

12	Complement System Proteins (Complement)IBA 02/2024 - 08/2012
6	AntibodiesIBA 01/2021 - 04/2008
4	Abatacept (Orencia)FDA Link 09/2023 - 11/2010
3	eculizumab FDA Link 12/2019 - 07/2013
2	COVID-19 VaccinesIBA 12/2022 - 12/2021
2	Monoclonal AntibodiesIBA 01/2022 - 07/2013
2	Rituximab (Mabthera)FDA Link 01/2022 - 12/2010
2	SteroidsIBA 01/2020 - 08/2009
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2019 - 07/2011
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2019 - 08/2009
2	Antiviral Agents (Antivirals)IBA 04/2018 - 12/2017
2	CreatinineIBA 12/2010 - 09/2007
1	Complement Factor I (C3b Inactivator)IBA 02/2024
1	Immunoglobulins (Immunoglobulin)IBA 11/2023
1	chemotactic factor inactivatorIBA 11/2023
1	BNT162 VaccineIBA 12/2022
1	Messenger RNA (mRNA)IBA 12/2022
1	sotrovimabIBA 01/2022
1	VaccinesIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	CTLA-4 AntigenIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 12/2019
1	InterferonsIBA 12/2017
1	Ribavirin (Virazole)FDA LinkGeneric 12/2017
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 08/2017
1	Diacylglycerol KinaseIBA 08/2017
1	Shiga Toxin (Shigella Toxin)IBA 08/2017
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2017
1	CD40 Ligand (CD40L)IBA 01/2017
1	AntigensIBA 05/2015
1	Anti-Infective Agents (Microbicides)IBA 10/2014
1	Complement C3 Nephritic FactorIBA 08/2012
1	Antigen-Antibody Complex (Immune Complex)IBA 08/2012
1	Membrane Cofactor ProteinIBA 08/2012
1	Complement Factor H (Factor H)IBA 08/2012
1	Antihypertensive Agents (Antihypertensives)IBA 01/2012
1	TOR Serine-Threonine KinasesIBA 12/2011
1	CalciumIBA 01/2011
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2011

Therapy/Procedure

16	Kidney Transplantation 02/2024 - 08/2009
9	Transplantation 01/2017 - 08/2009
6	Therapeutics 02/2024 - 04/2008
2	Injections 12/2021 - 04/2008
2	Organ Transplantation 01/2020 - 01/2017
1	Immunotherapy 11/2023
1	Glycemic Control 11/2023
1	Drug Tapering 05/2019
1	Drug Therapy (Chemotherapy) 12/2017
1	Patient Readmission 10/2014